SE462259B - Farmaceutiskt preparat innehaallande bromokriptin i ett fettsyraestermatrisgranulat och en cellulosahydrokolloid samt dess anvaendning - Google Patents

Farmaceutiskt preparat innehaallande bromokriptin i ett fettsyraestermatrisgranulat och en cellulosahydrokolloid samt dess anvaendning

Info

Publication number
SE462259B
SE462259B SE8500961A SE8500961A SE462259B SE 462259 B SE462259 B SE 462259B SE 8500961 A SE8500961 A SE 8500961A SE 8500961 A SE8500961 A SE 8500961A SE 462259 B SE462259 B SE 462259B
Authority
SE
Sweden
Prior art keywords
bromocriptine
capsule
preparation according
granulate
hydrocolloid
Prior art date
Application number
SE8500961A
Other languages
English (en)
Swedish (sv)
Inventor
O Zueger
N Mazer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE462259B publication Critical patent/SE462259B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8500961A 1984-02-29 1985-02-27 Farmaceutiskt preparat innehaallande bromokriptin i ett fettsyraestermatrisgranulat och en cellulosahydrokolloid samt dess anvaendning SE462259B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (1)

Publication Number Publication Date
SE462259B true SE462259B (sv) 1990-05-28

Family

ID=10557324

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8500961A SE462259B (sv) 1984-02-29 1985-02-27 Farmaceutiskt preparat innehaallande bromokriptin i ett fettsyraestermatrisgranulat och en cellulosahydrokolloid samt dess anvaendning
SE8500961D SE8500961L (sv) 1984-02-29 1985-02-27 Bromokriptinkompositioner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8500961D SE8500961L (sv) 1984-02-29 1985-02-27 Bromokriptinkompositioner

Country Status (26)

Country Link
JP (1) JPS60202812A (es)
AT (1) AT387716B (es)
AU (2) AU586621B2 (es)
BE (1) BE901810A (es)
CA (1) CA1256374A (es)
CH (2) CH666406A5 (es)
DE (1) DE3505743C2 (es)
DK (1) DK175016B1 (es)
ES (1) ES8705223A1 (es)
FR (1) FR2560047B1 (es)
GB (1) GB8405227D0 (es)
GR (1) GR850506B (es)
HK (1) HK85490A (es)
HU (1) HU196121B (es)
IE (1) IE58235B1 (es)
IL (1) IL74459A (es)
IT (1) IT1199948B (es)
LU (1) LU85791A1 (es)
MX (1) MX9203626A (es)
NL (1) NL194231C (es)
NZ (1) NZ211247A (es)
PH (1) PH23266A (es)
PT (1) PT80015B (es)
SE (2) SE462259B (es)
SG (1) SG69390G (es)
ZA (1) ZA851546B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265428A (es) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Also Published As

Publication number Publication date
DK86785D0 (da) 1985-02-26
MX9203626A (es) 1992-09-01
JPS60202812A (ja) 1985-10-14
PT80015B (pt) 1987-09-18
IL74459A (en) 1988-12-30
ES540807A0 (es) 1987-05-01
NL194231B (nl) 2001-06-01
GB8405227D0 (en) 1984-04-04
PT80015A (pt) 1986-02-10
IT8547703A1 (it) 1986-08-20
FR2560047A1 (fr) 1985-08-30
CA1256374A (en) 1989-06-27
PH23266A (en) 1989-06-23
IT1199948B (it) 1989-01-05
NL194231C (nl) 2001-10-02
DK86785A (da) 1985-08-30
SE8500961L (sv) 1985-08-30
HK85490A (en) 1990-10-25
IT8547703A0 (it) 1985-02-20
NL8500417A (nl) 1985-09-16
AU618599B2 (en) 1992-01-02
CH666406A5 (de) 1988-07-29
DK175016B1 (da) 2004-04-26
ZA851546B (en) 1986-10-29
IE58235B1 (en) 1993-08-11
ES8705223A1 (es) 1987-05-01
CH667009A5 (de) 1988-09-15
SE8500961D0 (sv) 1985-02-27
BE901810A (fr) 1985-08-26
AT387716B (de) 1989-03-10
AU3500689A (en) 1989-09-14
HU196121B (en) 1988-10-28
DE3505743A1 (de) 1985-08-29
IL74459A0 (en) 1985-05-31
AU3913685A (en) 1985-09-05
ATA58085A (de) 1988-08-15
HUT38254A (en) 1986-05-28
IE850495L (en) 1985-08-29
GR850506B (es) 1985-06-28
JPH0448776B2 (es) 1992-08-07
SG69390G (en) 1990-10-26
DE3505743C2 (de) 1995-02-16
AU586621B2 (en) 1989-07-20
FR2560047B1 (fr) 1988-01-15
NZ211247A (en) 1989-02-24
LU85791A1 (fr) 1985-12-11

Similar Documents

Publication Publication Date Title
KR890002949B1 (ko) 경구용 약제 조성물의 제조방법
AU613663B2 (en) Sustained release etodolac
AU639334B2 (en) Taste masking and sustained release coatings for pharmaceuticals
TW389696B (en) Accelerated release composition containing bromocriptine
US6238689B1 (en) Intestinal absorption of nicotine to treat nicotine responsive conditions
ES2301537T3 (es) Comprimidos y formulacion de guaifenesina de liberacion sostenida.
TWI282286B (en) Pharmaceutical composition a bilayer tablet having an immediate release phase of paracetamol and a sustained release phase of paracetamol
AU2001260212A1 (en) Composition
GB2154874A (en) Bromocriptine compositions
EP0152292A2 (en) Acetaminophen gelatin capsules
US20040229939A1 (en) Tetrahydrocannabinol compositions and methods of manufacture and use thereof
PT85128B (pt) Processo para a preparacao de composicoes farmaceuticas contendo, como ingrediente activo, 4-(1-metil-4-piperidilideno)-4h-benzo-{4,5}ciclohepta{1,2-b}tiofeno--10(9h)-ona
JP5241978B2 (ja) 漢方ゼリー医薬組成物
IL106743A (en) Tablets with enhanced bioavailability of claudonic acid
JP2016104812A (ja) ロキソプロフェンナトリウム及びトラネキサム酸を含有する固形製剤
SE462259B (sv) Farmaceutiskt preparat innehaallande bromokriptin i ett fettsyraestermatrisgranulat och en cellulosahydrokolloid samt dess anvaendning
PT85880B (pt) Processo para a preparacao de composicoes farmaceuticas de accao retardada contendo como substancia veicular uma mistura de celulose microcristalina com hidroxipropil-metilcelulose
KR101697773B1 (ko) 독소필린을 포함하는 변형 방출 조성물
CN111150713B (zh) 一种吲达帕胺胶囊及其制备方法
US5626872A (en) Pharmaceutical soft capsules containing lysine clonixinate and a process for their preparation
KR920008817B1 (ko) 조절된 방출성(서방성) 약학적 제제의 제조방법.
CN117205164B (zh) 一种盐酸沙丙蝶呤片剂及其制备方法
JP4854115B2 (ja) 無水パロキセチン用安定製剤形
AU2002325404B2 (en) Extended Release Tiagabine Formulations with Reduced Side-effects
KR950007229B1 (ko) 케토티펜을 함유한 약학적 조성물

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8500961-1